AVRO
Income statement / Annual
Last year (2023), AVROBIO, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, AVROBIO, Inc.'s net income was $12.16 M.
See AVROBIO, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$617,000.00 |
$4.17 M |
$1.40 M |
$1.21 M |
$850,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$617,000.00 |
-$4.17 M |
-$1.40 M |
-$1.21 M |
-$850,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$47.08 M
|
$72.19 M
|
$83.11 M
|
$87.24 M
|
$54.97 M
|
$35.10 M
|
$15.19 M
|
$2.66 M
|
| General & Administrative
Expenses |
$22.69 M
|
$33.25 M
|
$35.73 M
|
$32.99 M
|
$20.84 M
|
$11.15 M
|
$3.20 M
|
$1.96 M
|
| Selling & Marketing
Expenses |
$23.94 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$23.97 M
|
$33.25 M
|
$35.73 M
|
$32.99 M
|
$20.84 M
|
$11.15 M
|
$3.20 M
|
$1.96 M
|
| Other Expenses |
$0.00 |
-$456,000.00 |
-$285,000.00 |
$516,000.00 |
$2.84 M |
-$118,000.00 |
-$19,000.00 |
-$6,000.00 |
| Operating Expenses |
$71.05 M |
$105.43 M |
$118.84 M |
$120.23 M |
$75.81 M |
$46.24 M |
$18.39 M |
$4.63 M |
| Cost And Expenses |
$71.67 M |
$105.43 M |
$118.84 M |
$120.23 M |
$75.81 M |
$46.24 M |
$18.39 M |
$4.63 M |
| Interest Income |
$2.42 M |
$299.00 |
$0.00 |
$719,000.00 |
$2.93 M |
$1.73 M |
$57,000.00 |
$6,000.00 |
| Interest Expense |
$2.42 M |
$299,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$617,000.00
|
$1.44 M
|
$1.40 M
|
$1.21 M
|
$850,000.00
|
$380,000.00
|
$45,000.00
|
$39,000.00
|
| EBITDA |
-$71.05 M
|
-$105.43 M
|
-$118.84 M
|
-$120.23 M
|
-$75.81 M
|
-$46.24 M
|
-$18.04 M
|
-$4.59 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$2.34 M
|
-$456,000.00
|
-$285,000.00
|
$516,000.00
|
$2.84 M
|
-$118,000.00
|
-$262,000.00
|
-$39,000.00
|
| Income Before Tax |
$12.53 M |
-$105.89 M |
-$119.13 M |
-$119.71 M |
-$72.97 M |
-$46.36 M |
-$18.65 M |
-$4.66 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$377,000.00 |
$157,000.00 |
-$1.40 M |
-$1.21 M |
-$850,000.00 |
-$118,000.00 |
$243,000.00 |
-$6,000.00 |
| Net Income |
$12.16 M |
-$106.05 M |
-$117.73 M |
-$118.51 M |
-$72.12 M |
-$46.36 M |
-$18.65 M |
-$4.66 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
0.27 |
-2.42 |
-2.75 |
-3.27 |
-2.63 |
-3.45 |
-1.15 |
-0.67 |
| EPS Diluted |
0.27 |
-2.42 |
-2.75 |
-3.27 |
-2.63 |
-3.45 |
-1.15 |
-0.67 |
| Weighted Average Shares
Out |
$44.33 M
|
$43.74 M
|
$42.85 M
|
$36.21 M
|
$27.43 M
|
$13.44 M
|
$16.19 M
|
$6.92 M
|
| Weighted Average Shares
Out Diluted |
$44.57 M
|
$43.74 M
|
$42.85 M
|
$36.21 M
|
$27.43 M
|
$13.44 M
|
$16.19 M
|
$6.92 M
|
| Link |
|
|
|
|
|
|
|
|
